Skip to main content

Barclays Remains a Hold on Smith & Nephew (SN)

Tipranks - Tipranks - Thu Feb 12, 6:26AM CST

In a report released today, Hassan Al-Wakeel from Barclays maintained a Hold rating on Smith & Nephew, with a price target of £12.90.

Valentine's Day Sale - 70% Off

Al-Wakeel covers the Healthcare sector, focusing on stocks such as Straumann Holding AG, EssilorLuxottica SA, and Koninklijke Philips N.V.. According to TipRanks, Al-Wakeel has an average return of 0.0% and a 46.88% success rate on recommended stocks.

Smith & Nephew has an analyst consensus of Moderate Buy, with a price target consensus of p1,465.50.

See Insiders’ Hot Stocks on TipRanks >>

Based on Smith & Nephew’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p2.99 billion and a net profit of p295.65 million. In comparison, last year the company earned a revenue of p2.83 billion and had a net profit of p214 million

Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SN in relation to earlier this year.

Read More on GB:SN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).